Articles

While medical innovations offer tremendous appeal, investors can still get a discount in this sector via undervalued biotech stocks to buy. More

A recession is in the cards for 2023, and investors should capitalize on it by unloading these three overvalued stocks to sell. More

After a persistent drawdown, SOFI stock should appeal to contrarian investors as well as insider-buying enthusiasts. More

MULN stock is on the move as financial traders consider a Mullen insider's share sale as well as a delayed but crucial meeting. More

MMAT stock might have comeback potential in 2023 as Meta Materials teams up with a wide variety of tech-focused businesses. More

MULN stock could avoid delisting, and even stay on the Russell 2000, but Mullen needs a lot more cash to make its promised electric vehicles. More

As analysts predict poor holiday sales, Bed Bath & Beyond, and BBBY stock, one of 2021's "meme stocks," may not make it through 2023. More

Subscriber Sign in